BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30625524)

  • 1. Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.
    Deconinck E; Van Campenhout R; Aouadi C; Canfyn M; Bothy JL; Gremeaux L; Blanckaert P; Courselle P
    Talanta; 2019 Apr; 195():142-151. PubMed ID: 30625524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening method for rapid classification of psychoactive substances in illicit tablets using mid infrared spectroscopy and PLS-DA.
    Pereira LSA; Lisboa FLC; Coelho Neto J; Valladão FN; Sena MM
    Forensic Sci Int; 2018 Jul; 288():227-235. PubMed ID: 29777946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
    Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
    Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ecstasy tablets: comparison of reflectance and transmittance near infrared spectroscopy.
    Schneider RC; Kovar KA
    Forensic Sci Int; 2003 Jul; 134(2-3):187-95. PubMed ID: 12850416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
    Cheng WC; Poon NL; Chan MF
    J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Library Search-Based Screening System for 3,4-Methylenedioxymethamphetamine in Ecstasy Tablets Using a Portable Near-Infrared Spectrometer.
    Tsujikawa K; Yamamuro T; Kuwayama K; Kanamori T; Iwata YT; Miyamoto K; Kasuya F; Inoue H
    J Forensic Sci; 2016 Sep; 61(5):1208-14. PubMed ID: 27362667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening experiments of ecstasy street samples using near infrared spectroscopy.
    Sondermann N; Kovar KA
    Forensic Sci Int; 1999 Dec; 106(3):147-56. PubMed ID: 10680063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
    Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
    Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A turn-on fluorogenic probe for detection of MDMA from ecstasy tablets.
    Moreno D; Díaz de Greñu B; García B; Ibeas S; Torroba T
    Chem Commun (Camb); 2012 Mar; 48(24):2994-6. PubMed ID: 22314849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004.
    Giraudon I; Bello PY
    Subst Use Misuse; 2007; 42(10):1567-78. PubMed ID: 17918027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.
    Giroud C; Augsburger M; Rivier L; Mangin P; Sadeghipour F; Varesio E; Veuthey JL; Kamalaprija P
    J Anal Toxicol; 1998 Sep; 22(5):345-54. PubMed ID: 9737327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mCPP: an undesired addition to the ecstasy market.
    Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
    J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-Methylenedioxymethamphetamine quantification via benchtop
    Frinculescu A; Maier AFG; Shine T; Ramsey J; Araneda JF; Riegel SD; Frascione N; Abbate V
    J Pharm Biomed Anal; 2022 May; 214():114728. PubMed ID: 35349940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is online information on ecstasy tablet content safe?
    Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ
    Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impurity profiling of seized MDMA tablets by capillary gas chromatography.
    Palhol F; Boyer S; Naulet N; Chabrillat M
    Anal Bioanal Chem; 2002 Sep; 374(2):274-81. PubMed ID: 12324849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
    Parrott AC
    Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
    Kalasinsky KS; Hugel J; Kish SJ
    J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-site forensic analysis of colored seized materials: Detection of brown heroin and MDMA-tablets by a portable NIR spectrometer.
    Kranenburg RF; Ramaker HJ; van Asten AC
    Drug Test Anal; 2022 Oct; 14(10):1762-1772. PubMed ID: 35968822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS.
    Cunha RL; Oliveira CDSL; de Oliveira AL; Maldaner AO; do Desterro Cunha S; Pereira PAP
    Forensic Sci Int; 2023 Mar; 344():111597. PubMed ID: 36801502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
    Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
    Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.